Anura Telehealth Platform Enables Mobile Devices to Integrate Digital Health Solutions

NuraLogix, a contactless health monitoring company, showcased a host of new capabilities of its Anura platform at Mobile World Congress (MWC) 2023. Using mobile and desktop devices, Anura is able to provide over 30 health parameters allowing the mobile industry to integrate digital health solutions into various aspects of the healthcare industries and sectors such as retail, automotive and smart cities.

At MWC 2023, NuraLogix is showcasing its latest ability to perform metabolic and blood biomarker health risk assessments for various chronic conditions, such as assessing HbA1c and fasting glucose, as well as the risk of type 2 diabetes, hypertension, and hypertriglyceridemia. 

Anura is the only video-based contactless health monitoring technology that can measure vital signs and provide health risk assessments using mobile and desktop devices. Unlike smartwatches, health trackers, and rings that track blood flow through light sensors, Anura can do so with a video selfie. 

The platform is powered by NuraLogix's patented Transdermal Optical Imaging technology, a novel form of Remote Photoplethysmography. It automatically detects a person's face, identifies key regions of interest, and extracts blood flow information that is combined with powerful AI data models developed from tens of thousands of patients with multiple health conditions. 

Results are delivered within an intuitive results screen, showing information on dozens of health parameters such as heart rate, breathing rate, and cuffless blood pressure. It provides health risk assessments for some of the most prevalent chronic conditions, including Type 2 Diabetes, Hypertension, Cardiovascular Disease, and Mental Health. 

Click here to read the original news story.

Looking for expert insights in Virtual Care Delivery? Join the HealthXL Masterclass on ‘Current State of Routes to Market in Digital Health’ on 28th March. Click here to Request to Join.